Review article: Lactose - A potential prebiotic

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 9, 2002, Pages 1591-1602

  Szilagyi, A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LACTASE; LACTOSE; PROBIOTIC AGENT;

BACTERIAL METABOLISM; DIET THERAPY; ENZYME ACTIVITY; HEALTH HAZARD; HUMAN; INTESTINE FLORA; LACTOSE INTOLERANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

BETA-GALACTOSIDASE; DAIRY PRODUCTS; HUMANS; INTESTINAL DISEASES; INTESTINES; LACTASE; LACTOSE; LACTOSE INTOLERANCE; PROBIOTICS;

EID: 0036733327     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01321.x     Document Type: Review

References (145)

1. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance
2. Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics
3. The human lactase-phlorizin hydrolase gene is located on chromosome 2
4. Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia
5. Lactase persistence versus decline in human adults: Multifactorial events are involved in down-regulation after weaning
6. The genetically programmed down-regulation of lactase in children
7. The regulation of lactase expression in adult life
8. Dietary lactose and the aetiology of human small-intestinal hypolactasia
9. Levels and factors of control of small intestinal lactase expression in the laboratory rat
10. Lactase activity is under hormonal control in the intestine of adult rat
11. Effect of cortisone on developmental pattern of neutral and acid β-galactosidase of the small intestine of the rat
12. Opposite effects of one and three injections of cortisone or thyroxine on intestinal lactase activity in suckling mice
13. Intestinal lactase activity in suckling rats. Influence of hypophysectomy and thyroidectomy
14. Thyroid hormone differentially regulates rat intestinal brush border enzyme gene expression
15. Lactase in man: A nonadaptable enzyme
16. Reversible lactose malabsorption and intolerance in Graves' disease
17. Improved lactose digestion during pregnancy: A case of physiologic adaptation?
18. Improved lactose handling in late phase pregnancy
19. Caco-2 cell dissaccharidase activities are unaffected by gestational hormones
20. Influence of Loperamide on lactose handling and oral caecal transit time
21. Colonic adaptation to daily lactose feeding in lactose maldigesters
22. Prospective comparison of indirect methods for detecting lactase deficiency
23. 2) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients
24. A simple method of measuring breath hydrogen in carbohydrate malabsorption by end-expiratory sampling
25. New principle for estimation of hydrogen in expired air
26. 2 criteria
27. Carbohydrate absorption and malabsorption
28. Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with post vagotomy diarrhea
29. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin
30. Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrates
31. Fecal hydrogen production and consumption measurements. Response to daily lactose ingestion by lactose maldigesters
32. A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance
33. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance
34. Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerance
35. Tolerance to small amounts of lactose in lactose maldigesters
36. Sugar malabsorption in functional bowel disease: Clinical implications
37. Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: Comparison with lactose maldigestion/malabsorption
38. Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters
39. Do lipids play a role in milk intolerance?
40. The ileal brake - Inhibition of jejunal motility after ileal fat perfusion in man
41. Intraileal carbohydrate regulates canine postprandial pancreaticobiliary secretion and upper gut motility
42. Jejunal brake: Inhibition of intestinal transit by fat in the proximal small intestine
43. Effects of somatostatin on luminal transit and absorption of nutrients in the proximal gut of minipigs
44. Lactose malabsorption in Ethiopian children
45. Lactose intolerance in Iran
46. Lactose malabsorption in Greek adults: Correlation of small bowel transit time with the severity of lactose intolerance
47. The relationship between lactose tolerance test results and symptoms of lactose intolerance
48. Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: A placebo effect?
49. Possible therapeutic use of loperamide for symptoms of lactose intolerance
50. Improved parameters of lactose maldigestion using lactulose
51. Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose
52. Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener
53. Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly
54. The geographic hypothesis and lactose malabsorption. A weighing of the evidence
55. High intestinal lactase concentrations in adult Arabs in Saudi Arabia
56. Lactose nutrition and natural selection
57. Did malaria select for primary adult lactase deficiency?
58. Lactose absorption in patients with glucose 6-phosphate dehydrogenase deficiency with and without favism
59. Milk and other dietary influences on coronary heart disease
60. Epidemiological evidence for the link between dietary lactose and atherosclerosis
61. Galactose consumption and metabolism in relation to the risk of ovarian cancer
62. Lactase persistence and milk consumption as determinants of ovarian cancer risk
63. A case-control study of milk-drinking and ovarian cancer risk
64. Milk consumption ad cataract formation: Impairment of galactose metabolism in elderly and diabetic subjects
65. A role for milk phospholipids in protection against gastric acid. Studies in adult and suckling rats
66. Lactase deficiency: Prevalence in osteoporosis
67. Intestinal absorption of calcium, lactose malabsorption and osteoporosis
68. Effect of acetate and propionate on calcium absorption from the rectum and distal colon of humans
69. Lactose malabsorption is associated with early signs of mental depression in females: A preliminary report
70. Hypolactasia and ulcerative colitis
71. Hydrogen breath test quantification and clinical correlation of lactose malabsorption in adult irritable bowel syndrome and ulcerative colitis
72. Cow's milk protein sensitivity during infancy in patients with inflammatory bowel disease
73. Altered colonic environment, a possible predisposition to colorectal cancer and colonic inflammatory bowel disease: Rationale of dietary manipulation with emphasis on disaccharides
74. Calcium and the prevention of colon cancer
75. Dairy foods and prevention of colon cancer
76. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: A French case-control study
77. Calcium supplements for the prevention of colorectal adenomas
78. Calcium supplementation modifies the relative amounts of bile acids in bile and affects key aspects of human colon physiology
79. Calcium chemoprevention in colorectal cancer
80. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: A randomized controlled trial
81. Protective role of probiotics and prebiotics in colon cancer
82. Randomized double-blinded placebo-controlled intervention study with supplemental calcium in families with hereditary non polyposis colorectal cancer
83. The effect of calcium supplements on rectal mucosal proliferation
84. Effect of longterm placebo controlled calcium supplementation on sigmoidal cell proliferation in patients with sporadic adenomatous polyps
85. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders
86. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease
87. Experimental models of inflammatory bowel disease
88. Probiotics: The other half of the antibiotic story
89. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease
90. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
91. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
92. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor
93. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
94. Probiotics: Effects on immunity
95. Inflammatory bowel disease: Lessons from the IL-10 gene-deficient mouse
96. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination
97. Probiotic bacteria enhance murine and human intestinal epithelial barrier function
98. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein
99. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability
100. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A
101. Diminished efficacy of colonic adaptation to lactulose occurs in patients with inflammatory bowel disease in remission
102. Reducing sulfur compounds of the colon impair colonocyte nutrition: Implications for ulcerative colitis
103. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis
104. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
105. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
106. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
107. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
108. Saccharomyces boulardii in maintenance treatment of Crohn's disease
109. Bacteria and aetiology of cancer of large bowel
110. Increased serum deoxycholic acid levels in men with colorectal adenomas
111. Bile acid receptors in colorectal cancer
112. Roles of endogenous substances and bacteria in colorectal cancer
113. Utilization of nutrients by isolated epithelial cells of the rat colon
114. Lack of butyrate is associated with induction of Bax and subsequent apoptosis in the proximal colon of guinea pig
115. Butyrate acts as a survival factor for colonic epithelial cells: Further fuel for the in vivo versus in vitro debate
116. Association between intraepithelial Escherichia coli and colorectal cancer
117. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
118. Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients
119. Protective role of probiotics and prebiotics in colon cancer
120. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
121. Oral bacteriotherapy for viral gastroenteritis
122. Viable versus inactivated lactobacillus strain GG in acute rota virus diarrhea
123. The effects of Bifido-bacterium breve administration on campylobacter enteritis
124. Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care
125. Infection limitation with lactulose therapy
126. Influence of lactose on faecal microflora in lactose maldigesters
127. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters
128. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation
129. Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora. Studies in vivo and in vitro
130. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study)
131. Lactulose - A potential drug for the treatment of inflammatory bowel disease
132. Relations between rotatory power and structure in the sugar group XXVII: Synthesis of a new disaccharide ketose (lactulose) from lactose
133. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients
134. Effect of lactulose on the composition and metabolic activity of the human fecal flora
135. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients
136. Effects of resistant starch on the colon in healthy volunteers: Possible implications for cancer prevention
137. Does sucrase deficiency in black South Africans protect against colonic disease?
138. Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study
139. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: A multicentre study of bile salts and lactulose
140. Lactulose therapy in shigella carrier state and acute dysentery
141. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis
142. Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: Additive effects of dietary lactulose and calcium
143. Effect of long term lactulose ingestion on secondary bile salt metabolism in man: Potential protective effect of lactulose in colonic carcinogenesis
144. Numerical taxonomy of Lactobacillus ssp. associated with healthy and diseased mucosa of the human intestines
145. Lactose digestion and tolerance in adult and elderly Asian Americans